Ma Y, VanKeulen-Miller R, Fenton O
Nat Protoc. 2025; .
PMID: 40069324
DOI: 10.1038/s41596-024-01134-4.
Tang Z, Huang Z, Huang Y, Huang M, Liu H, Du J
J Nanobiotechnology. 2025; 23(1):158.
PMID: 40025537
PMC: 11874145.
DOI: 10.1186/s12951-025-03210-7.
Faderin E, Iorkula T, Aworinde O, Awoyemi R, Awoyemi C, Acheampong E
Med Oncol. 2025; 42(2):42.
PMID: 39789336
DOI: 10.1007/s12032-024-02598-w.
Sadaqa E, Satrialdi , Kurniawan F, Mudhakir D
Beilstein J Nanotechnol. 2025; 15:1667-1685.
PMID: 39764068
PMC: 11702302.
DOI: 10.3762/bjnano.15.131.
Kuriyama M, Hirose H, Kawaguchi Y, Michibata J, Maekawa M, Futaki S
Mol Ther. 2025; 33(2):595-614.
PMID: 39748507
PMC: 11852704.
DOI: 10.1016/j.ymthe.2024.12.050.
Enhancing the Efficacy of Radiation Therapy by Photochemical Internalization of Fibrin-Hydrogel-Delivered Bleomycin.
Laurel S, Gupta K, Nguyen J, Chandekar A, Le J, Berg K
Cancers (Basel). 2024; 16(23).
PMID: 39682215
PMC: 11640518.
DOI: 10.3390/cancers16234029.
Research Progress on Cyclic-Peptide Functionalized Nanoparticles for Tumor-Penetrating Delivery.
Wang C, Shen Z, Chen Y, Wang Y, Zhou X, Chen X
Int J Nanomedicine. 2024; 19:12633-12652.
PMID: 39624118
PMC: 11609414.
DOI: 10.2147/IJN.S487303.
Delivering therapeutic RNA into the brain using extracellular vesicles.
Shirmast P, Shahri M, Brent A, Idris A, McMillan N
Mol Ther Nucleic Acids. 2024; 35(4):102373.
PMID: 39618821
PMC: 11607666.
DOI: 10.1016/j.omtn.2024.102373.
Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook.
Patel S, Salaman S, Kapoor D, Yadav R, Sharma S
Z Naturforsch C J Biosci. 2024; .
PMID: 39566511
DOI: 10.1515/znc-2024-0208.
Charge-guided masking of a membrane-destabilizing peptide enables efficient endosomal escape for targeted intracellular delivery of proteins.
Zhao Y, Jiang H, Chen H, Yu J, Wang L, Zhou W
Acta Pharm Sin B. 2024; 14(10):4478-4492.
PMID: 39525569
PMC: 11544179.
DOI: 10.1016/j.apsb.2024.06.022.
Tackling Anticancer Drug Resistance and Endosomal Escape in Aggressive Brain Tumors Using Bioelectronics.
Jain A, Wade P, Stolnik S, Hume A, Kerr I, Coyle B
ACS Omega. 2024; 9(42):42923-42931.
PMID: 39464448
PMC: 11500143.
DOI: 10.1021/acsomega.4c05794.
Peptide-coated DNA nanostructures as a platform for control of lysosomal function in cells.
Elblova P, Lunova M, Henry S, Tu X, Cale A, Dejneka A
Chem Eng J. 2024; 498.
PMID: 39372137
PMC: 11448966.
DOI: 10.1016/j.cej.2024.155633.
Subcellular Drug Distribution: Exploring Organelle-Specific Characteristics for Enhanced Therapeutic Efficacy.
Liu X, Li M, Woo S
Pharmaceutics. 2024; 16(9).
PMID: 39339204
PMC: 11434838.
DOI: 10.3390/pharmaceutics16091167.
Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear.
Foster T, Lim P, Ionescu C, Wagle S, Kovacevic B, Mooranian A
Ther Deliv. 2024; 15(10):801-818.
PMID: 39324734
PMC: 11457609.
DOI: 10.1080/20415990.2024.2389032.
Intracellular delivery strategies using membrane-interacting peptides and proteins.
Mai L, Wimberley S, Champion J
Nanoscale. 2024; 16(33):15465-15480.
PMID: 39091235
PMC: 11340348.
DOI: 10.1039/d4nr02093f.
Development of an extended action fostemsavir lipid nanoparticle.
Islam F, Das S, Ashaduzzaman M, Sillman B, Yeapuri P, Nayan M
Commun Biol. 2024; 7(1):917.
PMID: 39080401
PMC: 11289258.
DOI: 10.1038/s42003-024-06589-5.
Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress.
Dume B, Licarete E, Banciu M
Mol Ther Nucleic Acids. 2024; 35(3):102256.
PMID: 39045515
PMC: 11264197.
DOI: 10.1016/j.omtn.2024.102256.
Achieving efficient clonal beta cells transfection using nanostraw/nanopore-assisted electroporation.
Ekstrand F, Mapar M, Ruhrmann S, Bacos K, Ling C, Prinz C
RSC Adv. 2024; 14(31):22244-22252.
PMID: 39010923
PMC: 11247384.
DOI: 10.1039/d4ra02791d.
Conditional Cell-Penetrating Peptide Exposure as Selective Nanoparticle Uptake Signal.
Walter M, Bresinsky M, Zimmer O, Pockes S, Goepferich A
ACS Appl Mater Interfaces. 2024; 16(29):37734-37747.
PMID: 39010308
PMC: 11284753.
DOI: 10.1021/acsami.4c07821.
Liposome nanoparticle conjugation and cell penetrating peptide sequences (CPPs) enhance the cellular delivery of the tau aggregation inhibitor RI-AG03.
Reich N, Parkin E, Dawson N
J Cell Mol Med. 2024; 28(11):e18477.
PMID: 38853458
PMC: 11163028.
DOI: 10.1111/jcmm.18477.